Merck LiteSpark-001: Advanced rCC progression after immunotherapy

Research Grant

Duke Scholars

Principal Investigator Michael Roger Harrison Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Merck Sharp & Dohme

Start Date

July 28, 2022

End Date

October 10, 2023

Administered By

Duke Cancer Institute

Awarded By

Merck Sharp & Dohme

Start Date

July 28, 2022

End Date

October 10, 2023